| 000 | 01538nam a2200349 a 4500 | ||
|---|---|---|---|
| 003 | EG-GiCUC | ||
| 005 | 20250223025921.0 | ||
| 008 | 090902s2009 ua dh f m 000 0 eng d | ||
| 040 |
_aEG-GiCUC _beng _cEG-GiCUC |
||
| 041 | 0 | _aeng | |
| 049 | _aDeposite | ||
| 097 | _aM.Sc | ||
| 099 | _aCai01.08.08.M.Sc.2009.He.B | ||
| 100 | 0 | _aHeba Ibrahim Mohamed Abdallah | |
| 245 | 1 | 0 |
_aBiopharmaceutical studies on certain plasma products / _cHeba Ibrahim Mohamed Abdallah ; Supervised Mahmoud Mohamed Ghorab , Medhat Deif |
| 246 | 1 | 5 | _aدراسة صيدلية لبعض مشتقات البلازما |
| 260 |
_aCairo : _bHeba Ibrahim Mohamed Abdallah , _c2009 |
||
| 300 |
_a188 P. : _bcharts , facsimiles ; _c25cm |
||
| 502 | _aThesis (M.Sc.) - Cairo University - Faculty Of Pharmacy - Department Of Pharmaceutics | ||
| 520 | _aThe work in this aimed to develop a method for production of safe freeze-dried FVIII with increased stability using different preparation methods of FVIII concentrates with viral inactivation techniques using polysaccharide stabilizers with the lyophilization technology in order to increase the safety and availability of FVIII in all environments | ||
| 530 | _aIssued also as CD | ||
| 653 | 4 | _aAl (OH)3 | |
| 653 | 4 | _aBeta | |
| 653 | 4 | _aFactor VIII | |
| 700 | 0 |
_aMahmoud Mohamed Ghorab , _eSupervisor |
|
| 700 | 0 |
_aMedhat Deif , _eSupervisor |
|
| 856 | _uhttp://172.23.153.220/th.pdf | ||
| 902 | _a1 | ||
| 905 |
_aEnas _eCataloger |
||
| 905 |
_aMustafa _eRevisor |
||
| 942 |
_2ddc _cTH |
||
| 999 |
_c23499 _d23499 |
||